Skip to main content
Premium Trial:

Request an Annual Quote

Hanne Dannulat, David Smith, Guy della Cioppa

Premium

Hanne Dannulat has joined San Diego-based Structural Bioinformatics as European managing director. Her responsibilities will include planning and management of SBI’s European commercial operation. Dannulat spent the last 15 years at GlaxoSmithKline and Glaxo Wellcome, and prior to that, three years at Lederle Labs. Her career spans positions ranging from office-based sales, hospital sales, marketing manager, business unit director, to commercial director. She has a bachelor of economics and a masters in business administration from Henley Management College in London.

David Smith has been appointed vice president of sales and marketing at Advion BioSciences. He will be responsible for building Advion’s North American sales team to support the company’s microtechnology products, including the NanoMate 100 automated nanoelectro- spray system, a chip-based system for high-throughput mass spectro metry analysis for proteomics. Smith brings over 15 years’ experience in the mass spectrometry industry to the Ithaca, NY-based company. As LC/MS/MS business unit director at Perkin-Elmer, he was responsible for the marketing, selling, and after-sales support of the company’s LC/MS/MS systems. Prior to Perkin-Elmer, Smith spent eleven years at Thermo Finnigan in marketing, engineering, and business unit management. More recently, he was the global sales manager for laboratory automation operations for Beckman Coulter. Smith holds a bachelor’s degree from Stockton State College and a master’s degree from Ohio State University.

Guy della Cioppa has joined Chicago-based NanoInk as executive vice president for business development. Prior to joining the nanochip startup, he spent 13 years at Large Scale Biology Corporation, most recently as vice president for business development. At LSBC, he helped prepare the company’s IPO. Prior to that, as vice president of the genomics division, he closed LSBC’s $53 million research collaboration with Dow Chemical. Before joining LSBC, he held various positions in corporate R&D at Monsanto. Della Cioppa holds a PhD in biology from the University of California, Los Angeles.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.